Oric Pharmaceuticals, Inc. ORIC Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Oric Pharmaceuticals, Inc. (ORIC) reported comprehensive income (loss), net of tax, attributable to parent of -$36.84M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 22.0% year-over-year, from -$30.19M to -$36.84M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 13.1% compound annual growth rate (CAGR), from -$78.79M to -$129.06M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric measures the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It serves as a comprehensive measure of a company's total financial performance and wealth generation during a specific period. Investors use this to understand the full scope of financial fluctuations that impact the company's book value beyond standard operating results.